Abbott Labs (ABT) PT Raised to $146 at Morgan Stanley

October 21, 2021 4:36 AM

Morgan Stanley analyst Cecilia Furlong raised the price target on Abbott Labs (NYSE: ABT) to $146.00 (from $136.00) while maintaining a Overweight rating.

No results found